Please select the option that best describes you:
Topics:
Bladder Cancer • Medical Oncology • Urology • Rheumatology • Rheumatoid Arthritis • Psoriatic arthritis • General Rheumatology • Infectious Disease
How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?
Assuming no symptoms of TB, should patients be treated for latent TB prior to starting TNF inhibitors or other immunosuppressive agents?
Answer from: at Academic Institution
Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumor immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer.
As rheumatologis...
Sign in or Register to read more